Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tavares

Showing results (481-490 of 491) with videos related to

Pageof 50
Sort By:
Journal of the American College of Cardiology|December 15, 2025
Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized TrialVagner Madrini, Paulo Vinicius Ramos Souza, Fabio Fernandes, et al.
JACC. Advances|September 2, 2025
Efficacy and Safety of a Novel Triple Single-Pill For Uncontrolled Hypertension: the OPTION TREAT TrialVagner Madrini, Caio A M Tavares, Monica T A Albuquerque, et al.
The Journal of Infectious Diseases|September 27, 2024
Rare Genetic Variants of NLRP12 in Admixed Latino-American Children With SARS-CoV-2-Related Multisystem Inflammatory SyndromeThaís M M Barreto, Roberta S Souza, Raquel B São Pedro, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
The Lancet. Respiratory Medicine|May 16, 2025
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trialsAlain Amstutz, Stefan Schandelmaier, Hannah Ewald, et al.
Frontiers in Toxicology|December 15, 2025
Hazard identification and characterization of leachable chemicals from plastic products - a new PARC projectHubert Dirven, Aleksandra Bogusz, Hans Bouwmeester, et al.
Journal of the American College of Cardiology|December 12, 2025
Potent P2Y<sub>12</sub> Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI: The NEO-MINDSET SubstudyCaio A M Tavares, Patricia O Guimarães, Marcelo Franken, et al.
European Heart Journal|December 18, 2025
Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trialCaio A M Tavares, Patricia O Guimarães, Marcelo Franken, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 12, 2023
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET TrialPatricia O Guimarães, Marcelo Franken, Caio A M Tavares, et al.
The New England Journal of Medicine|September 1, 2025
Early Withdrawal of Aspirin after PCI in Acute Coronary SyndromesPatricia O Guimarães, Marcelo Franken, Caio A M Tavares, et al.
Pageof 50

Showing results (481-490 of 491) with videos related to

Sort By:
Pageof 50
Journal of the American College of Cardiology|December 15, 2025
Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized TrialVagner Madrini, Paulo Vinicius Ramos Souza, Fabio Fernandes, et al.
JACC. Advances|September 2, 2025
Efficacy and Safety of a Novel Triple Single-Pill For Uncontrolled Hypertension: the OPTION TREAT TrialVagner Madrini, Caio A M Tavares, Monica T A Albuquerque, et al.
The Journal of Infectious Diseases|September 27, 2024
Rare Genetic Variants of NLRP12 in Admixed Latino-American Children With SARS-CoV-2-Related Multisystem Inflammatory SyndromeThaís M M Barreto, Roberta S Souza, Raquel B São Pedro, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
The Lancet. Respiratory Medicine|May 16, 2025
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trialsAlain Amstutz, Stefan Schandelmaier, Hannah Ewald, et al.
Frontiers in Toxicology|December 15, 2025
Hazard identification and characterization of leachable chemicals from plastic products - a new PARC projectHubert Dirven, Aleksandra Bogusz, Hans Bouwmeester, et al.
Journal of the American College of Cardiology|December 12, 2025
Potent P2Y<sub>12</sub> Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI: The NEO-MINDSET SubstudyCaio A M Tavares, Patricia O Guimarães, Marcelo Franken, et al.
European Heart Journal|December 18, 2025
Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trialCaio A M Tavares, Patricia O Guimarães, Marcelo Franken, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 12, 2023
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET TrialPatricia O Guimarães, Marcelo Franken, Caio A M Tavares, et al.
The New England Journal of Medicine|September 1, 2025
Early Withdrawal of Aspirin after PCI in Acute Coronary SyndromesPatricia O Guimarães, Marcelo Franken, Caio A M Tavares, et al.
Pageof 50